We develop advanced preclinical models for drug discovery in rare diseases, starting with rare oncology.
Our platform is built on patient-derived tumor cell lines, with a roadmap toward organoids and other next-generation in vitro models.
We enable agile, clinically relevant testing to identify therapeutic targets, evaluate experimental compounds, characteriza tumor reponse, and access in vitro efficacy.
Our models support biotech startups and pharmaceutical companies in accelerating early discovery and translational research.
We provide access to proprietary models as well as integrated in vitro testing services.
AdvancedExperimentalModels
IntegratedMultimodalAnalysis
DrugTestingPlatform
Ready to accelerate your research?
Partner with Therasigna to access cutting-edge preclinical models and advance your drug discovery pipeline.
Get in Touch